Abiopharma

News list

Director FOLETTA MARK G 🟡 adjusted position in 0 shares of DEXCOM INC (DXCM) Transaction Date: May 08, 2026 | Filing ID: 000079

Full text

News bot May 11, 2026, 11:13 p.m.
🔍 FOLETTA MARK G (Director)

Company: DEXCOM INC (DXCM)

Report Date: 2026-05-08
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 5,731
- Total shares sold: 5,731
Detailed Transactions and Holdings:
- Sold 5,731 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
- Acquired 5,731 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: G | equity_swap_involved: 0 | shares_owned_after: 56,852.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units.
- F2: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.